The incidence of the refeeding syndrome in cancer patients who receive artificial nutritional treatment

摘要: We determine the incidence of malnutrition syndrome and its relation with probable risk factors, in 106 patients, a mean age 53.3 +/- 15.4 years, diagnosis cancer confirmed histologically, who received artificial nutrition either enterally or endovenously, during an average 16.8 2 days, which included supply 60 to 100 mmol/day phosphorus. considered there be renutrition when as hypophosphatemia; < 2.5 mmol/l, took place nutritional treatment phase, previous which, patients had normal serum levels The electrolyte concentrations were measured prior start treatment, daily first week, later every 3 days until end. study variables were: age, sex, type cancer, degree malnutrition, hypophosphatemia, day on occurred, clinical manifestations associated this. relative was calculated for cancer. 24.5%; it more frequent enteral group than endovenous (37.5% vs. 18.9%, p 0.005); 72 hours after starting support, 61.5% cases, phosphorus 1.9 mmol/l; most neuromuscular ones (30%), lymphoma (15.4%). factors greater years (RR = 1.7), moderate severe 8RR 2.0). conclude that prevalence is high despite intense preventive